Related Experiment Video
Updated: Sep 5, 2025
12:42
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
9.6K
Oncolytic viruses: challenges and considerations in an evolving clinical landscape
Ulrich M Lauer1,2, Julia Beil1,2
1Department of Internal Medicine VIII, Virotherapy Center Tübingen, Medical Oncology & Pneumology, Medical University Hospital Tübingen, Otfried-Mueller-Str. 10, Tübingen, 72076, Germany.
Future Oncology (London, England)
|July 12, 2022
Summary
Oncolytic viruses (OVs) offer a promising new approach for treating difficult cancers. This review explores strategies to overcome challenges and advance OV therapy into clinical practice for resistant cancers.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Cancer remains a significant global health challenge, with many types evading current treatments and the immune system.
- Existing therapies face limitations due to cancer's evolved resistance mechanisms.
Purpose of the Study:
- To review the challenges and innovative strategies in developing oncolytic viruses (OVs) for cancer treatment.
- To explore the current clinical landscape and future prospects of OVs in cancer therapy.
Main Methods:
- Review of current literature on oncolytic virus development and clinical trials.
- Analysis of strategies to enhance OV efficacy and safety.
- Discussion of the translation of OV research into clinical practice.
Main Results:
- Oncolytic viruses can be engineered to selectively target cancer cells and stimulate anti-tumor immunity.
- Innovative strategies are emerging to optimize OV potential and overcome treatment resistance.
- OVs show promise in early clinical development for various cancers.
Conclusions:
- Oncolytic viruses represent a potential breakthrough for treatment-resistant cancers.
- Continued research and strategic development are crucial for realizing the full clinical potential of OVs.
- OVs are poised to become an important modality in the future of cancer treatment.
Related Concept Videos
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
01:28Preclinical Development: Overview
4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
01:29Microorganisms in Medicine and Therapeutics
305
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
305
01:30Cancer Vaccines
503
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
503
01:51Mechanisms of Retrovirus-induced Cancers
5.2K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K